Evaluation of a novel autoinjector for subcutaneous self-administration of belimumab in systemic lupus erythematosus

Objective: To study self-administration and pharmacokinetics (PK) of subcutaneous (SC) belimumab in patients with systemic lupus erythematosus (SLE). Methods: Patients previously treated with belimumab self-administered belimumab 200 mg SC weekly for 8 weeks using an autoinjector. The primary endpoi...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Int J Clin Pharmacol Ther
Egile Nagusiak: Sheikh, Saira Z., Hammer, Anne E., Fox, Norma Lynn, Groark, James, Struemper, Herbert, Roth, David, Gordon, David
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Dustri-Verlag Dr. Karl Feistle 2016
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5100660/
https://ncbi.nlm.nih.gov/pubmed/27668697
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5414/CP202623
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak